Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

204 ARTÍCULOS , VIENDO DEL 76 AL 90

EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease

Gaubert S, Raimondo F, Houot M, Corsi MC, Naccache L, Diego Sitt J, Hermann B, Oudiette D, Gagliardi G, Habert MO, Dubois B, De Vico Fallani F, Bakardjian H, Epelbaum S; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2019 Jul 1;142(7):2096-2112. doi: 10.1093/brain/awz150.

Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls

Nunes A, Silva G, Duque C, Januário C, Santana I, Ambrósio AF, Castelo-Branco M, Bernardes R.

PLoS One. 2019 Jun 21;14(6):e0218826. doi: 10.1371/journal.pone.0218826. eCollection 2019.

A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease

Herrera-Espejo S, Santos-Zorrozua B, Álvarez-González P, Lopez-Lopez E, Garcia-Orad Á.

Mol Neurobiol. 2019 Dec;56(12):8376-8391. doi: 10.1007/s12035-019-01676-9. Epub 2019 Jun 25.

Long Non-coding RNA BACE1-AS May Serve as an Alzheimer's Disease Blood-Based Biomarker

Fotuhi SN, Khalaj-Kondori M, Hoseinpour Feizi MA, Talebi M.

J Mol Neurosci. 2019 Nov;69(3):351-359. doi: 10.1007/s12031-019-01364-2. Epub 2019 Jul 1.

Interleukin 9 alterations linked to alzheimer disease in african americans

Wharton W, Kollhoff AL, Gangishetti U, Verble DD, Upadhya S, Zetterberg H, Kumar V, Watts KD, Kippels AJ, Gearing M, Howell JC, Parker MW, Hu WT.

Ann Neurol. 2019 Sep;86(3):407-418. doi: 10.1002/ana.25543. Epub 2019 Jul 22.

Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD)

Gagliardi G, Epelbaum S, Houot M, Bakardjian H, Boukadida L, Revillon M, Dubois B, Dalla Barba G, La Corte V; INSIGHT-preAD study group.

J Alzheimers Dis. 2019;70(3):811-824. doi: 10.3233/JAD-180966.

Novel Alzheimer's disease risk genes: exhaustive investigation is paramount

Sleegers K, Van Broeckhoven C.

Acta Neuropathol. 2019 Aug;138(2):171-172. doi: 10.1007/s00401-019-02041-9. Epub 2019 Jul 12.

Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease

Chen JJ, Yang G, Yan QQ, Zhao J, Li S.

Rev Neurosci. 2019 Dec 18;31(1):77-87. doi: 10.1515/revneuro-2019-0001.

MIND food and speed of processing training in older adults with low education, the MINDSpeed Alzheimer's disease prevention pilot trial

Clark DO, Xu H, Moser L, Adeoye P, Lin AW, Tangney CC, Risacher SL, Saykin AJ, Considine RV, Unverzagt FW.

Contemp Clin Trials. 2019 Sep;84:105814. doi: 10.1016/j.cct.2019.105814. Epub 2019 Jul 18.

Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer's disease: A case study

Morrill SJ, Gibas KJ.

Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1187-1191. doi: 10.1016/j.dsx.2019.01.035. Epub 2019 Jan 24.

The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

Tang KS.

Life Sci. 2019 Sep 15;233:116695. doi: 10.1016/j.lfs.2019.116695. Epub 2019 Jul 25.

Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease

Archetti D, Ingala S, Venkatraghavan V, Wottschel V, Young AL, Bellio M, Bron EE, Klein S, Barkhof F, Alexander DC, Oxtoby NP, Frisoni GB, Redolfi A; Alzheimer's Disease Neuroimaging Initiative; for EuroPOND Consortium.

Neuroimage Clin. 2019;24:101954. doi: 10.1016/j.nicl.2019.101954. Epub 2019 Jul 23.

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers

Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, van Duijn C, Saykin AJ, Kaddurah-Daouk R; Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium.

JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias